Dexamethasone sodium phosphate and Haematotoxicity - a phase IV clinical study of FDA data

Summary:

Haematotoxicity is reported as a side effect among people who take Dexamethasone sodium phosphate (dexamethasone sodium phosphate), especially for people who are female, 60+ old, also take Cyclophosphamide, and have Schizoaffective disorder.

The phase IV clinical study analyzes which people have Haematotoxicity when taking Dexamethasone sodium phosphate. It is created by eHealthMe based on reports of 12,016 people who have side effects when taking Dexamethasone sodium phosphate from the FDA, and is updated regularly.

What is Dexamethasone sodium phosphate?

Dexamethasone sodium phosphate has active ingredients of dexamethasone sodium phosphate. It is often used in multiple myeloma. eHealthMe is studying from 12,101 Dexamethasone sodium phosphate users. Check the latest studies of Dexamethasone sodium phosphate.

What is Haematotoxicity?

Haematotoxicity (toxins that destroy red blood cells) is found to be associated with 347 drugs and 821 conditions by eHealthMe. Check the latest studies of Haematotoxicity.

On Apr, 12, 2026

12,016 people reported to have side effects when taking Dexamethasone sodium phosphate.
Among them, 15 people (0.12%) have Haematotoxicity.

Could Dexamethasone sodium phosphate cause Haematotoxicity?

Among these 15 people:

What is the gender of people who have Haematotoxicity when taking Dexamethasone sodium phosphate? *

female: 58.33 %
male: 41.67 %

What is the age of people who have Haematotoxicity when taking Dexamethasone sodium phosphate? *

What are other drugs people take besides Dexamethasone sodium phosphate? *

What are other side effects people have besides Haematotoxicity? *

Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 4 people, 26.67%
Thrombocytopenia (decrease of platelets in blood): 3 people, 20.00%
Drug Ineffective: 2 people, 13.33%
Mucosal Inflammation (infection of mucous membrane): 2 people, 13.33%
Hypomania (a mild form of mania, marked by elation and hyperactivity): 2 people, 13.33%
Septic Shock (shock due to blood infection): 2 people, 13.33%
Fever: 2 people, 13.33%
Fatigue (feeling of tiredness): 2 people, 13.33%
White Blood Cell Count Decreased: 1 person, 6.67%
Headache (pain in head): 1 person, 6.67%

What are the existing conditions these people have? *

Schizoaffective Disorder (a mental disorder characterized by disordered thought): 2 people, 13.33%
Oesophageal Carcinoma (cancer tumour of oesophagus): 1 person, 6.67%
Acute Lymphocytic Leukaemia Recurrent (cancer in which the bone marrow makes too many lymphocytes-recurrent): 1 person, 6.67%
Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 1 person, 6.67%
Angiocentric Lymphoma (extra nodal natural killer cell cancer): 1 person, 6.67%
Burkitt's Leukaemia (blood cancer): 1 person, 6.67%
Burkitt's Lymphoma (cancer of the lymphatic system): 1 person, 6.67%
Extranodal Nk/t-Cell Lymphoma, Nasal Type (lymphoid cancer): 1 person, 6.67%
Glioblastoma (most common and most aggressive malignant primary brain tumour in humans): 1 person, 6.67%
Glioblastoma Multiforme (most common and deadliest of malignant primary brain tumours in adults): 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Dexamethasone sodium phosphate and have Haematotoxicity?

- Check whether Haematotoxicity is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Dexamethasone sodium phosphate:

Dexamethasone sodium phosphate (12,101 reports)

Haematotoxicity treatments and more:

Haematotoxicity (8,984 reports)

How severe was Haematotoxicity and when was it recovered:

Haematotoxicity in Dexamethasone sodium phosphate

Expand to all the drugs that have ingredients of dexamethasone sodium phosphate:

Haematotoxicity and drugs with ingredients of dexamethasone sodium phosphate

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Dexamethasone sodium phosphate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Haematotoxicity:

Haematotoxicity (347 drugs)

Browse all the conditions that are associated with Haematotoxicity:

Haematotoxicity (821 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on dexamethasone sodium phosphate (the active ingredients of Dexamethasone sodium phosphate) and Dexamethasone sodium phosphate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.